Form 4: Tenet Healthcare COO Lisa Foo Reports Stock Transactions

Tenet Healthcare's EVP and Chief Operating Officer, Lisa Y. Foo, reported the vesting of restricted stock units and subsequent tax-related share dispositions.

Summary

• Lisa Y. Foo, EVP, Chief Operating Officer of Tenet Healthcare Corp, reported multiple transactions on February 27, 2026.
• Acquired 4,670 shares of common stock through the conversion of 2024 February Restricted Stock Units.
• Acquired 4,199 shares of common stock through the conversion of 2023 March Restricted Stock Units.
• Disposed of 1,838 shares of common stock at $237.58 to satisfy withholding taxes upon vesting of performance share units.
• Disposed of 4,289 shares of common stock at $239.39 for tax payment upon vesting of restricted stock units.
• Disposed of 13,706 shares of common stock at $239.39 for tax payment upon vesting of restricted stock units.
• Acquired 7,520 new 2026 February Restricted Stock Units, which vest in one-third increments on the first, second, and third anniversaries of the grant date.
• Following these transactions, Lisa Y. Foo directly beneficially owns 42,053 shares of common stock and 7,520 derivative restricted stock units.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. While there are share dispositions for tax purposes, the underlying event is the vesting of equity awards and the grant of new RSUs, indicating ongoing executive compensation and alignment with company performance.

Positives

• Vesting of restricted stock units indicates the achievement of performance or time-based criteria, reflecting successful tenure or company performance.
• Acquisition of new 2026 February Restricted Stock Units aligns management incentives with long-term shareholder value.

Negatives

• Significant disposition of shares (19,833 shares in total) to cover tax obligations reduces the executive's direct equity stake in the company.

Future Outlook

The filing indicates future vesting events for the 2026 February Restricted Stock Units, which are scheduled to vest in one-third increments on the first, second, and third anniversaries of their grant date.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as RSU vesting and tax-related sales, are common across the healthcare industry as part of executive compensation plans. These transactions typically reflect pre-scheduled events rather than discretionary trading based on new material information, distinguishing them from open market purchases or sales that might signal management's view on future performance.

Comparison to Industry Standards

• The structure of restricted stock unit grants with multi-year vesting schedules and tax withholding upon vesting is a standard practice in executive compensation across major U.S. publicly traded companies, including those in the healthcare sector.
• This aligns executive incentives with long-term company performance and shareholder value creation, similar to compensation plans at peers like HCA Healthcare or Universal Health Services.

Stakeholder Impact

• Shareholders: The transactions represent routine executive compensation events and do not indicate a significant shift in the company's operational or financial outlook. The executive's overall beneficial ownership remains substantial.
• Employees: The vesting of RSUs is a standard component of executive compensation, which can be a positive signal for employee morale regarding the company's compensation structure.

Next Steps

• Future vesting of the remaining two-thirds increments of the 2026 February Restricted Stock Units on their respective anniversaries.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation, specifically the vesting of restricted stock units and subsequent tax-related share dispositions. These are pre-scheduled events and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation. The executive continues to hold a significant stake, aligning her interests with shareholders.

Keywords

Tenet Healthcare, THC, Lisa Y. Foo, Insider Trading, Form 4, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Transactions, Healthcare